Therapeutic Effect of Human Placenta Biologics on Improving Immune System Ability

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000031801

Enrollment

Unknown

Registered

2020-04-10

Start date

2020-03-31

Completion date

Unknown

Last updated

2020-04-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Control group:Conventional therapy

Experimental group:Conventional therapy and taking human placenta biologics

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Aged 35-90 years old; 2. Healthy or sub-healthy people; 3. Sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Pregnant women; 2. With history of clinically diagnosed mental illness, experience of taking or injecting psychotropic drugs.

Design outcomes

Primary

Measure	Time frame
Routine blood test;Immune indices;	—

Contacts

Public ContactWei Wei

Guangzhou Reborn Health Management Consultation Co., Ltd.

wwei@chinacord.org+86 13729856651

Outcome results